Omni
Omni ships weekly, and almost every week the headline item is an AI feature.
A side-by-side editorial comparison of DoseFinding and silx — release velocity, themes, recent moves, and the top alternatives to consider.
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
silx settles into maintenance a release after its PySide6 migration
silx is in the quiet phase after a generational release. 3.1.1 is a single fix to FitWidget loading a fit function from file. The release before it, 3.1.0, was the first real feature work since the migration - asinh axis scaling, twilight colormaps, and dark-theme icons - and 3.0.1 was similarly small. The 3.0.0 cut that reset the Qt binding and Python floor still defines what the line is doing.
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.
Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.
silx is in the quiet phase after a generational release. 3.1.1 is a single fix to FitWidget loading a fit function from file. The release before it, 3.1.0, was the first real feature work since the migration - asinh axis scaling, twilight colormaps, and dark-theme icons - and 3.0.1 was similarly small. The 3.0.0 cut that reset the Qt binding and Python floor still defines what the line is doing.
The cadence has slowed markedly since April, and the content has shifted from structural change to plotting and colormap refinement. That is the expected shape after a binding migration: downstream beamline code needs a stable target, so the project trades feature velocity for a quiet surface. The gap between 3.0.1 in May and 3.1.0 in August is the clearest signal of the deliberate slowdown.
Expect further point releases servicing the plotting and fitting widgets rather than another structural change, with feature work continuing to arrive in the 3.1.x minors rather than patches.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either DoseFinding or silx.
Omni ships weekly, and almost every week the headline item is an AI feature.
Plotly is turning its cloud into a metered compute platform with an enterprise on-ramp.
aniread stops asking you to know which tracker wrote the file
Rho's release machinery finally produced a stable build — and it shipped no new product.
Usermaven closed the loop: data comes in from anywhere, and now it goes back out.
OpenCTI spends a release unblocking queues and hardening upserts
See all DoseFinding alternatives → · See all silx alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. silx is currently shipping more aggressively (velocity 5.0 vs 0.0), with 0 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. silx is currently shipping more aggressively (velocity 5.0 vs 0.0), with 0 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.
Top silx alternatives in Analytics are ranked by recent ship velocity. Browse the "silx alternatives" section above for the current picks, or visit /alternatives/silx for the full list with editorial commentary on each.